BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Policy

  UK Court Backs Teva Pharmaceutical Industries Limited Rival To AstraZeneca PLC Lung Drug Symbicort

  September 3, 2014

   · 

  6 min read
• Business

  Nabriva Therapeutics Appoints Dr. Colin Broom As CEO

  September 3, 2014

   · 

  4 min read
• Drug Development

  RedHill Biopharma Ltd. Initiates Phase 3 Study Of RHB-102 For Gastroenteritis

  September 3, 2014

   · 

  10 min read
• Drug Development

  Ultragenyx Pharmaceuticals Announces Positive Interim Data From Phase 1/2 Study Of Recombinant Human Beta-Glucuronidase In Mucopolysaccharidosis 7

  September 3, 2014

   · 

  5 min read
• Drug Development

  Rhizen Pharmaceuticals S.A. To Present Preclinical Data Of Their First-In-Class Inflammation Assets, RP6503 And RP3128 For Treatment Of Various Respiratory Diseases

  September 3, 2014

   · 

  2 min read
• Biotech Bay

  ReVance Therapeutics, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

  September 3, 2014

   · 

  2 min read
• Business

  Celator Pharmaceuticals, Inc. Announces Appointment Of Michael Dougherty As Chairman Of The Board

  September 3, 2014

   · 

  3 min read
• Bio NC

  Chimerix, Inc. To Present At The Morgan Stanley Healthcare Conference

  September 3, 2014

   · 

  1 min read
• Biotech Beach

  Zogenix, Inc. To Participate In Morgan Stanley Global Healthcare Conference 2014

  September 3, 2014

   · 

  1 min read
• Biotech Beach

  Otonomy, Inc. Announces Full Exercise Of Underwriters’ Option To Purchase Additional Shares

  September 3, 2014

   · 

  2 min read